MARKET WRAP: Aspen boosts JSE gains with biggest rise in 20 years on vaccination deal

Pharmaceutical manufacturer Aspen and gold miner AngloGold Ashanti led the JSE higher on Monday with the local bourse getting a boost from positive economic data, while investor focus now shifts to the US elections on Tuesday.

Shares in Aspen Pharmacare rose the most since April 2000, up 11.45% to R117.64, after the group said it hadreached a preliminary agreement to produce US drugmaker Johnson & Johnson’s candidate Covid-19 vaccine at its facility in Port Elizabeth.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Risk of sharp yield swings hangs over US bond marketWall Street dealers are split over whether debt sales will set another record high or remain at current levels
Источник: BDliveSA - 🏆 12. / 63 Прочитайте больше »

BUSINESS MAVERICK: Covid-19 vaccine could be made in SAMultinational firm Johnson & Johnson has selected Aspen Pharmacare as one of the companies to manufacture its Covid-19 vaccine, once it has the go-ahead for commercial production. Is the NorthWestDOH contributing in any way or form, DlaminiZuma DrZweliMkhize MokgoroJob
Источник: dailymaverick - 🏆 3. / 84 Прочитайте больше »